|
1
|
Dye C, Scheele S, Dolin P, Pathania V and
Raviglione MC: Consensus statement. Global burden of tuberculosis:
estimated incidence, prevalence, and mortality by country. WHO
Global Surveillance and Monitoring Project. JAMA. 282:677–686.
1999. View Article : Google Scholar
|
|
2
|
Bhatt K and Salgame P: Host innate immune
response to Mycobacterium tuberculosis. J Clin Immunol.
27:347–362. 2007. View Article : Google Scholar
|
|
3
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Underhill DM, Ozinsky A, Smith KD and
Aderem A: Toll-like receptor-2 mediates mycobacteria-induced
proinflammatory signaling in macrophages. Proc Natl Acad Sci USA.
96:14459–14463. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Quesniaux V, Fremond C, Jacobs M, et al:
Toll-like receptor pathways in the immune responses to
mycobacteria. Microbes Infect. 6:946–959. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Holscher C, Reiling N, Schaible UE, et al:
Containment of aerogenic Mycobacterium tuberculosis infection in
mice does not require MyD88 adaptor function for TLR2, -4 and -9.
Eur J Immunol. 38:680–694. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cole ST, Brosch R, Parkhill J, et al:
Deciphering the biology of Mycobacterium tuberculosis from
the complete genome sequence. Nature. 393:537–544. 1998.
|
|
8
|
Boom WH, Husson RN, Young RA, David JR and
Piessens WF: In vivo and in vitro characterization of murine T-cell
clones reactive to Mycobacterium tuberculosis. Infect Immun.
55:2223–2229. 1987.PubMed/NCBI
|
|
9
|
Brightbill HD, Libraty DH, Krutzik SR, et
al: Host defense mechanisms triggered by microbial lipoproteins
through toll-like receptors. Science. 285:732–736. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Diaz-Silvestre H, Espinosa-Cueto P,
Sanchez-Gonzalez A, et al: The 19-kDa antigen of Mycobacterium
tuberculosis is a major adhesin that binds the mannose receptor
of THP-1 monocytic cells and promotes phagocytosis of mycobacteria.
Microb Pathog. 39:97–107. 2005.
|
|
11
|
Sanchez A, Espinosa P, Garcia T and
Mancilla R: The 19 kDa Mycobacterium tuberculosis lipoprotein
(LpqH) induces macrophage apoptosis through extrinsic and intrinsic
pathways: a role for the mitochondrial apoptosis-inducing factor.
Clin Dev Immunol. 2012:9505032012. View Article : Google Scholar
|
|
12
|
Kuo ML, Huang TS and Lin JK: Curcumin, an
antioxidant and anti-tumor promoter, induces apoptosis in human
leukemia cells. Biochim Biophys Acta. 1317:95–100. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goel A, Kunnumakkara AB and Aggarwal BB:
Curcumin as ‘Curecumin’: from kitchen to clinic. Biochem Pharmacol.
75:787–809. 2008.
|
|
14
|
Marathe SA, Dasgupta I, Gnanadhas DP and
Chakravortty D: Multifaceted roles of curcumin: two sides of a
coin! Expert Opin Biol Ther. 11:1485–1499. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bukhari SN, Franzblau SG, Jantan I and
Jasamai M: Current prospects of synthetic curcumin analogs and
chalcone derivatives against Mycobacterium tuberculosis. Med
Chem. 9:897–903. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kawamori T, Lubet R, Steele VE, et al:
Chemopreventive effect of curcumin, a naturally occurring
anti-inflammatory agent, during the promotion/progression stages of
colon cancer. Cancer Res. 59:597–601. 1999.PubMed/NCBI
|
|
17
|
Lu YP, Chang RL, Lou YR, et al: Effect of
curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B
light-induced expression of c-Jun and c-Fos in JB6 cells and in
mouse epidermis. Carcinogenesis. 15:2363–2370. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Azuine MA and Bhide SV: Chemopreventive
effect of turmeric against stomach and skin tumors induced by
chemical carcinogens in Swiss mice. Nutr Cancer. 17:77–83. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shuto T, Ono T, Ohira Y, et al: Curcumin
decreases toll-like receptor-2 gene expression and function in
human monocytes and neutrophils. Biochem Biophys Res Commun.
398:647–652. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schlesinger LS, Bellinger-kawahara CG,
Payne NR and Horwitz MA: Phagocytosis of Mycobacterium
tuberculosis is mediated by human monocyte complement receptors
and complement component-C3. J Immunol. 144:2771–2780.
1990.PubMed/NCBI
|
|
21
|
Sanchez A, Espinosa P, Garcia T and
Mancilla R: The 19 kDa Mycobacterium tuberculosis lipoprotein
(LpqH) induces macrophage apoptosis through extrinsic and intrinsic
pathways: a role for the mitochondrial apoptosis-inducing factor.
Clin Dev Immunol. 2012:9505032012. View Article : Google Scholar
|
|
22
|
Lopez M, Sly LM, Luu Y, Young D, Cooper H
and Reiner NE: The 19-kDa Mycobacterium tuberculosis protein
induces macrophage apoptosis through toll-like receptor-2. J
Immunol. 170:2409–2416. 2003.
|
|
23
|
Thangapazham RL, Sharma A and Maheshwari
RK: Multiple molecular targets in cancer chemoprevention by
curcumin. AAPS J. 8:E443–E449. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Singh RP and Agarwal R: Mechanisms of
action of novel agents for prostate cancer chemoprevention. Endocr
Relat Cancer. 13:751–778. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Salehi P, Makhoul G, Roy R, Malhotra M,
Mood ZA and Daniel SJ: Curcumin loaded NIPAAM/VP/PEG-A
nanoparticles: physicochemical and chemopreventive properties. J
Biomater Sci Polym Ed. 24:574–588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lopez-Lazaro M: Anticancer and
carcinogenic properties of curcumin: considerations for its
clinical development as a cancer chemopreventive and
chemotherapeutic agent. Mol Nutr Food Res. 52(Suppl 1): S103–S127.
2008.
|
|
27
|
Campbell FC and Collett GP:
Chemopreventive properties of curcumin. Future Oncol. 1:405–414.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ammon HP and Wahl MA: Pharmacology of
Curcuma longa. Planta Med. 57:1–7. 1991.
|
|
29
|
Jee SH, Shen SC, Tseng CR, Chiu HC and Kuo
ML: Curcumin induces a p53-dependent apoptosis in human basal cell
carcinoma cells. J Invest Dermatol. 111:656–661. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Uddin S, Hussain AR, Manogaran PS, et al:
Curcumin suppresses growth and induces apoptosis in primary
effusion lymphoma. Oncogene. 24:7022–7030. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sen S, Sharma H and Singh N: Curcumin
enhances Vinorelbine mediated apoptosis in NSCLC cells by the
mitochondrial pathway. Biochem Biophys Res Commun. 331:1245–1252.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Singh S and Aggarwal BB: Activation of
transcription factor NF-kappa B is suppressed by curcumin
(diferuloylmethane) [corrected]. J Biol Chem. 270:24995–25000.
1995.
|
|
33
|
Bush JA, Cheung KJ Jr and Li G: Curcumin
induces apoptosis in human melanoma cells through a Fas
receptor/caspase-8 pathway independent of p53. Exp Cell Res.
271:305–314. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Watanabe I, Ichiki M, Shiratsuchi A and
Nakanishi Y: TLR2-mediated survival of Staphylococcus aureus
in macrophages: a novel bacterial strategy against host innate
immunity. J Immunol. 178:4917–4925. 2007.PubMed/NCBI
|
